IDEAYA Biosciences, Inc. Quarterly Debt-to-equity in % from Q1 2020 to Q2 2024

Taxonomy & unit: ratio: %
Description: Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary: IDEAYA Biosciences, Inc. quarterly Debt-to-equity history and growth rate from Q1 2020 to Q2 2024.
IDEAYA Biosciences, Inc. Debt-to-equity for the quarter ending June 30, 2024 was 4.05 %, a 54.2% decline year-over-year.

Debt-to-equity, Quarterly (%)

Debt-to-equity, YoY Quarterly Growth (%)

Period	Value	YoY Chg	Change %	Date
Q2 2024	4.05	-4.8	-54.2%	Jun 30, 2024
Q1 2024	4.1	-9.54	-69.9%	Mar 31, 2024
Q4 2023	5.6	-11.6	-67.4%	Dec 31, 2023
Q3 2023	7.11	-14.1	-66.5%	Sep 30, 2023
Q2 2023	8.85	-16.7	-65.3%	Jun 30, 2023
Q1 2023	13.6	-14.2	-51.1%	Mar 31, 2023
Q4 2022	17.2	-14.2	-45.2%	Dec 31, 2022
Q3 2022	21.2	-15.5	-42.1%	Sep 30, 2022
Q2 2022	25.5	-19.1	-42.8%	Jun 30, 2022
Q1 2022	27.9	-11.1	-28.5%	Mar 31, 2022
Q4 2021	31.4	-3.92	-11.1%	Dec 31, 2021
Q3 2021	36.7	+10.9	+42.2%	Sep 30, 2021
Q2 2021	44.6	+34.1	+324%	Jun 30, 2021
Q1 2021	39	+27.1	+228%	Mar 31, 2021
Q4 2020	35.3			Dec 31, 2020
Q3 2020	25.8			Sep 30, 2020
Q2 2020	10.5			Jun 30, 2020
Q1 2020	11.9			Mar 31, 2020

* An asterisk sign (*) next to the value indicates that the value is likely invalid.